Gri Bio, INC. (GRI) — DEFA14A Filings
All DEFA14A filings from Gri Bio, INC.. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (1)
-
GRI BIO Files Proxy Statement Supplement
— Aug 16, 2024 Risk: low
GRI BIO, Inc. (formerly Vallon Pharmaceuticals, Inc.) filed a Definitive Additional Materials (DEFA14A) document on August 16, 2024. This filing supplements the
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX